Immunicum AB (publ) Publishes the Annual Report for 2019
April 03, 2020 02:00 ET
|
Immunicum AB
Press Release 3 April 2020 Immunicum AB (publ) Publishes the Annual Report for 2019 Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2019 is now available on the...
Immunicum AB (publ) meddelar att Peter Suenaert återvänder till sin roll som Chief Medical Officer
March 30, 2020 02:00 ET
|
Immunicum AB
Pressmeddelande 30 mars 2020 Immunicum AB (publ) meddelar att Peter Suenaert återvänder till sin roll som Chief Medical Officer Immunicum AB (publ) meddelade idag att Peter Suenaert, MD, PhD,...
Immunicum AB (publ) Announces Peter Suenaert to Resume Role as Chief Medical Officer
March 30, 2020 02:00 ET
|
Immunicum AB
Press Release 30 March 2020 Immunicum AB (publ) Announces Peter Suenaert to Resume Role as Chief Medical Officer Immunicum AB (publ) announced today that Peter Suenaert, MD, PhD, will resume the...
Kallelse till årsstämma i Immunicum AB (publ)
March 27, 2020 07:00 ET
|
Immunicum AB
Pressmeddelande 27 mars 2020 Kallelse till årsstämma i Immunicum AB (publ) Aktieägarna i Immunicum AB (publ) (”Bolaget”), org.nr 556629-1786, kallas härmed till årsstämma tisdagen den 28 april...
Notice of Annual General Meeting in Immunicum AB (publ)
March 27, 2020 07:00 ET
|
Immunicum AB
Press Release 27 March 2020 Notice of Annual General Meeting in Immunicum AB (publ) The shareholders of Immunicum AB (publ) (the “Company”), reg. no 556629-1786, are hereby invited to the...
American Gene Technologies to Present at 2020 Inborn Errors of Metabolism Drug Development Summit in Boston
March 10, 2020 09:34 ET
|
American Gene Technologies
ROCKVILLE, Md., March 10, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), a leading gene and cell therapy company in Rockville, Maryland, is pleased to announce its Chief Science Officer C....
Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research
March 10, 2020 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Premier patient traité dans l’essai de Phase I évaluant IPH5201 chez des patients atteints de tumeurs solides avancées
March 10, 2020 02:00 ET
|
INNATE PHARMA
Démarrage du premier essai clinique avec IPH5201, un anticorps monoclonal anti-CD39, première molécule de la collaboration étendue entre Innate et AstraZeneca à avancer au stade clinique Innate...
First patient dosed in IPH5201 Phase I clinical trial in advanced solid tumors
March 10, 2020 02:00 ET
|
INNATE PHARMA
Anti-CD39 monoclonal antibody, IPH5201, advances to first-in-human clinical trial; first molecule from Innate/AstraZeneca expanded collaboration progressing to the clinic Innate Pharma SA (Euronext...
Immunicum AB (publ) meddelar att bolagets finanschef, Michaela Gertz, lämnar sin tjänst till sommaren 2020
March 02, 2020 05:30 ET
|
Immunicum AB
Pressmeddelande 2 mars 2020 Immunicum AB (publ) meddelar att bolagets finanschef, Michaela Gertz, lämnar sin tjänst till sommaren 2020 Immunicum AB (publ) meddelar att bolagets finanschef...